Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Molecular Cancer
|
October 21, 2016
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing
Valentina Kovaleva, Anna-Lena Geissler, Lisa Lutz, et al.
Oncotarget
|
February 16, 2017
ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer
Anna-Lena Geißler, Miriam Geißler, Daniel Kottmann, et al.
Human Pathology
|
July 29, 2008
Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q
Marc-Oliver Riener, Elisabeth Nikolopoulos, Alexander Herr, et al.
American Journal of Cancer Research
|
May 7, 2016
Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro
Lisa Lutz, Ingrid Coutiño Fitzner, Theresa Ahrens, et al.
Human Pathology
|
February 5, 2011
The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia
Konrad Aumann, Silke Lassmann, Anja Schöpflin, et al.
Gastroenterology
|
December 7, 2007
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
Silke Lassmann, Laura Tang, Marinela Capanu, et al.
Histochemistry and Cell Biology
|
December 3, 2013
ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes
Annette M May, Anna-Verena Frey, Lioudmila Bogatyreva, et al.
Leukemia Research
|
February 21, 2015
Therapeutic polo-like kinase 1 inhibition results in mitotic arrest and subsequent cell death of blasts in the bone marrow of AML patients and has similar effects in non-neoplastic cell lines
Claudia Münch, Diana Dragoi, Anna-Verena Frey, et al.
Epigenetics
|
April 30, 2015
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine
Theresa D Ahrens, Sylvia Timme, Jens Hoeppner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2006
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Rudolf Reiter, Peter Gais, Uta Jütting, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Molecular Cancer
|
October 21, 2016
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing
Valentina Kovaleva, Anna-Lena Geissler, Lisa Lutz, et al.
Oncotarget
|
February 16, 2017
ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer
Anna-Lena Geißler, Miriam Geißler, Daniel Kottmann, et al.
Human Pathology
|
July 29, 2008
Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q
Marc-Oliver Riener, Elisabeth Nikolopoulos, Alexander Herr, et al.
American Journal of Cancer Research
|
May 7, 2016
Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro
Lisa Lutz, Ingrid Coutiño Fitzner, Theresa Ahrens, et al.
Human Pathology
|
February 5, 2011
The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia
Konrad Aumann, Silke Lassmann, Anja Schöpflin, et al.
Gastroenterology
|
December 7, 2007
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
Silke Lassmann, Laura Tang, Marinela Capanu, et al.
Histochemistry and Cell Biology
|
December 3, 2013
ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes
Annette M May, Anna-Verena Frey, Lioudmila Bogatyreva, et al.
Leukemia Research
|
February 21, 2015
Therapeutic polo-like kinase 1 inhibition results in mitotic arrest and subsequent cell death of blasts in the bone marrow of AML patients and has similar effects in non-neoplastic cell lines
Claudia Münch, Diana Dragoi, Anna-Verena Frey, et al.
Epigenetics
|
April 30, 2015
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine
Theresa D Ahrens, Sylvia Timme, Jens Hoeppner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2006
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Rudolf Reiter, Peter Gais, Uta Jütting, et al.
Page
of 8